Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 529 - 536 of 12142 results

USPTO Takes a Hint from European Practice in Addressing Late Continuation Concerns
December 19, 2024| Blog| Viewpoint

Congress Passes Defense Bill with AI Provisions — AI: The Washington Report
December 19, 2024| Article| Viewpoint

Canada’s Fall Economic Statement: A Silver Lining for Innovators Amidst the Chaos
December 18, 2024| Alert| Viewpoint

Preparation for 2024 Fiscal Year-End SEC Filings and 2025 Annual Shareholder Meetings
December 17, 2024| Advisory| Viewpoint

Mintz on Air: Predictions and Practical Policies – Workplace Whiplash
December 17, 2024| Podcast| Viewpoint

Dealmaking Dormant No More
December 17, 2024| News

How Johnson v. Parker-Hannifin Impacts Professional Fiduciaries And 401k Plan Sponsors
December 17, 2024| News

Feds’ Decision to Transfer $1.9B Public Pension Surplus to General Revenue Within Its Purview
December 16, 2024| News
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
